Yvonne Greenstreet, CEO of Alnylam Pharmaceuticals, joined Flagship Pioneering Founder and CEO Noubar Afeyan in our Flagship Studio for a FutureCast conversation on what’s unique about leading a platform company, balancing breadth versus depth when it comes to pipeline development, and how a commitment to the science and a shared vision fuels innovation. More from Flagship @ JPM2025 here.
More from:
Human Health
Pioneering Partnerships: Advancing a Portfolio of Novel Medicines and Vaccines with GSK
Pioneering Partnerships: Accelerating our Collaboration with Pfizer
Unlocking Therapeutic Breakthroughs with the Power of Platform Technologies
Halting the Trajectory of Disease with Preemptive Health
AI in Action
